The Relevance of Selenium Status in Rheumatoid Arthritis.
Study Goal
The researchers aimed to review the current knowledge about the relevance of selenium (Se) status in rheumatoid arthritis (RA) and its potential modulating effect on inflammation and oxidative stress.
Results Summary
Clinical trials on Se supplementation in RA showed no significant results, but experimental studies using novel Se nanoparticles demonstrated promising effects on restoring antioxidant enzyme levels, particularly glutathione peroxidase (GPx). RA patients often have altered serum Se levels and a deficient diet, which may influence disease activity.
Population
Rheumatoid arthritis (RA) patients
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
diet | increase | inflammation | - | - | can aggravate or attenuate | #1 |
deficient diet in some food groups | increase | parameters of disease activity | RA patients | - | is associated with | #2 |
- | neutral | serum Se levels | RA patients | - | there is an alteration in | #3 |
Se supplementation | no change | - | RA patients | no significant results | no significant results were obtained | #4 |
novel Se nanoparticles | increase | antioxidant enzyme levels | RA-induced models | - | have shown promising results on the restoration of | #5 |
glutathione peroxidase (GPx) | decrease | inflammation | RA patients | - | could have a modulating effect on | #6 |
Rheumatoid arthritis (RA) is an autoimmune and inflammatory disease that can cause joint damage. Among the environmental risk factors, diet plays an important role because it can aggravate or attenuate inflammation. Selenium (Se) is considered an essential trace element since it is a structural component of antioxidant enzymes; however, its concentration can be affected by diet, drugs and genetic polymorphisms. Studies have reported that RA patients have a deficient diet in some food groups that is associated with parameters of disease activity. Furthermore, it has been shown that there is an alteration in serum Se levels in this population. Although some clinical trials have been conducted in the past to analyze the effect of Se supplementation in RA, no significant results were obtained. Contrastingly, experimental studies that have evaluated the effect of novel Se nanoparticles in RA-induced models have shown promising results on the restoration of antioxidant enzyme levels. In particular, glutathione peroxidase (GPx) is an important selenoprotein that could have a modulating effect on inflammation in RA. Considering that RA patients present an inflammatory and oxidative state, the aim of this review is to give an overview of the current knowledge about the relevance of Se status in RA.